Abigail Jenkins's Insider Trades & SAST Disclosures
Abigail Jenkins's most recent trade in Aquestive Therapeutics Inc was a trade of 57,000 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on May 10, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Abigail Jenkins.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Abigail L. Jenkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 57,000 | 57,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Gamida Cell Ltd | Abigail L. Jenkins | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.55 per share. | 30 Sep 2022 | 16,129 | 266,129 | - | 1.6 | 25,000 | Ordinary Shares |
| Gamida Cell Ltd | Abigail L. Jenkins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2022 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| Gamida Cell Ltd | Abigail L. Jenkins | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Sep 2022 | 250,000 | 250,000 | - | 0 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges